Imricor Medical Systems Inc (IMR) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.198x

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has a cash flow conversion efficiency ratio of -0.198x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.56 Million ≈ $-3.23 Million USD) by net assets (AU$23.08 Million ≈ $16.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Imricor Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Imricor Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Imricor Medical Systems Inc (IMR) total liabilities for a breakdown of total debt and financial obligations.

Imricor Medical Systems Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imricor Medical Systems Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
EUROKAI GmbH & Co. KGaA
F:EUK3
0.017x
Zhongtong Guomai Communication
SHG:603559
-0.131x
Huang Hsiang Construction Corp
TW:2545
-0.192x
Iteos Therapeutics Inc
NASDAQ:ITOS
-0.086x
Ram Ratna Wires Limited
NSE:RAMRAT
0.019x
Ganso Co Ltd
SHG:603886
0.101x
Hankook Shell Oil
KO:002960
0.127x
Tadiran Hldg
TA:TDRN
0.100x

Annual Cash Flow Conversion Efficiency for Imricor Medical Systems Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see IMR stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$-7.38 Million
≈ $-5.22 Million
AU$-15.57 Million
≈ $-11.02 Million
2.111x +42.40%
2023-12-31 AU$-8.75 Million
≈ $-6.19 Million
AU$-12.98 Million
≈ $-9.18 Million
1.483x +167.44%
2022-12-31 AU$7.51 Million
≈ $5.31 Million
AU$-16.51 Million
≈ $-11.68 Million
-2.198x -181.58%
2021-12-31 AU$22.40 Million
≈ $15.85 Million
AU$-17.49 Million
≈ $-12.37 Million
-0.781x -83.94%
2020-12-31 AU$28.82 Million
≈ $20.39 Million
AU$-12.23 Million
≈ $-8.65 Million
-0.424x +54.96%
2019-12-31 AU$7.03 Million
≈ $4.98 Million
AU$-6.63 Million
≈ $-4.69 Million
-0.942x -100.20%
2018-12-31 AU$13.47 Million
≈ $9.53 Million
AU$-6.34 Million
≈ $-4.49 Million
-0.471x -143.77%
2017-12-31 AU$-5.25 Million
≈ $-3.72 Million
AU$-5.65 Million
≈ $-4.00 Million
1.075x +6.98%
2016-12-31 AU$-4.03 Million
≈ $-2.85 Million
AU$-4.05 Million
≈ $-2.87 Million
1.005x --

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$448.50 Million
AU$633.87 Million AUD
Market Cap Rank
#13120 Global
#339 in Australia
Share Price
AU$1.98
Change (1 day)
+0.00%
52-Week Range
AU$1.20 - AU$2.20
All Time High
AU$2.79
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more